Tag Archives: Phil Nadeau

Cowen & Co. Assigns a Buy Rating on Syros Pharmaceuticals

In a report released today, Phil Nadeau from Cowen & Co. assigned a Buy rating to Syros Pharmaceuticals (NASDAQ: SYRS). The company’s shares opened today at $12.68. According to TipRanks.com, Nadeau is a 5-star analyst with an average return of

Analysts Are Bullish on Top Healthcare Stocks: Biogen Inc (BIIB), Viveve Medical Inc (VIVE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen Inc (NASDAQ:BIIB) and Viveve Medical Inc (NASDAQ:VIVE) with bullish sentiments. Biogen Inc (BIIB) In a report issued on July 6, Phil

Analysts Offer Insights on Healthcare Companies: Celgene (NASDAQ: CELG), Theravance Biopharma (NASDAQ: TBPH) and Axovant Sciences (NYSE: AXON)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Celgene (NASDAQ:CELG), Theravance Biopharma (NASDAQ:TBPH) and Axovant Sciences (NYSE:AXON). Celgene (CELG) In a report released yesterday, Phil Nadeau from Cowen & Co. maintained a Buy

Analysts Offer Insights on Healthcare Companies: Zafgen (NASDAQ: ZFGN) and Merrimack Pharmaceuticals (NASDAQ: MACK)

Analysts fell to the sidelines weighing in on Zafgen (NASDAQ: ZFGN) and Merrimack Pharmaceuticals (NASDAQ: MACK) with neutral ratings,indicating that the experts are neither bullish nor bearish on the stocks. Zafgen (NASDAQ: ZFGN) Cowen & Co. analyst Phil Nadeau maintained

PDL BioPharma Gets a Hold Rating from Cowen & Co.

In a report issued on June 12, Phil Nadeau from Cowen & Co. maintained a Hold rating on PDL BioPharma (NASDAQ: PDLI), with a price target of $2.50. The company’s shares closed yesterday at $2.70. According to TipRanks.com, Nadeau is

Cowen & Co. Assigns a Buy Rating on Galapagos NV

Cowen & Co. analyst Phil Nadeau assigned a Buy rating to Galapagos NV (NASDAQ: GLPG) yesterday. The company’s shares opened today at $101.83. According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 15.1% and a 57.9%